66266 Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices 

who play on natural grass fields will 

provide a comparison group and allow 

for evaluation of exposures to 

constituents in tire crumb rubber among 

synthetic turf field users. 

The respondents will be administered 

a detailed questionnaire on activity 

patterns on synthetic turf with crumb 

rubber infill. This instrument will be 

used to characterize exposure scenarios, 

including the nature and duration of 

potential exposures. Additionally, the 

questionnaire will include queries on 

potential external sources, such as 

dietary sources, to select chemicals. We 

will collect urine samples pre- and postactivity. The urine samples will be 

analyzed for polyaromatic hydrocarbons 

and also archived for future analysis in 

the event of new analytical methods for 

potential chemicals of interest. 

The research study will screen a total 

of 220 participants for eligibility. The 

target sample size for synthetic turf field 

users is 150 and 50 for the natural grass 

field users. The total burden hours for 

the research study is 184 hours among 

all of the 220 respondents. There is no 

cost to the respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs.) 

Total burden 

(in hrs.) 

Adult/Adolescent Field Users ............ Eligibility Screening Form ................ 110 1 5/60 9 

Adult and Adolescent Questionnaire 100 1 30/60 50 

Exposure Measurement Form ......... 100 1 20/60 33 

Parents/Guardians of Youth/Child 

Field Users.

Eligibility Screening Form ................ 110 1 5/60 9 

Youth and Child Questionnaire ........ 100 1 30/60 50 

Youth/Child Field Users .................... Exposure Measurement Form ......... 100 1 20/60 33 

Total ........................................... ........................................................... ........................ ........................ ........................ 184 

Jeffrey M. Zirger, 

Acting Lead, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of Science, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–27854 Filed 12–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Chief Operating Officer, CDC, 

pursuant to Public Law 92–463. The 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—DP19–004, 

Improving Detection and Management of 

Glaucoma and Other Eye Diseases Among 

High Risk Populations. 

Dates: March 26, 2019. 

Times: 10:00 a.m.–6:30 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman Ph.D., Scientific Review Officer, CDC, 

4770 Buford Highway, Mailstop F80, Atlanta, 

Georgia 30341, Telephone: (770) 488–6511, 

kva5@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27894 Filed 12–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Chief Operating Officer, CDC, 

pursuant to Public Law 92–463. The 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)–PS19–001, The GAIN 

(Greater Access and Impact with NAT). 

Study: Improving HIV Diagnosis, Linkage 

to Care, and Prevention Services with HIV 

Point-of-Care Nucleic Acid Tests (NATs). 

Date: April 11, 2019. 

Time: 10:00 a.m.–5:00 p.m., (EDT). 

Place: Teleconference, Centers for Disease 

Control and Prevention, Room 1080, 8 

Corporate Square Blvd., Atlanta, GA 30329. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Gregory 

Anderson, M.S., M.P.H., Scientific Review 

Officer, CDC, 1600 Clifton Road, NE, 

Mailstop E60, Atlanta, Georgia 30333, (404) 

718–8833, gca5@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 


amozie on DSK3GDR082PROD with NOTICES1